Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001096906-09-001137
Filing Date
2009-09-24
Accepted
2009-09-24 12:42:08
Documents
4
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 CHINA AOXING PHARMACEUTICAL COMPANY, INC. FORM 10-K/A JUNE 30, 2006 caxg10ka20060630.htm 10-K/A 698274
2 RULE 13A-14(A) CERTIFICATION - CEO caxg10ka20060630ex31-1.htm EX-31.1 8703
3 RULE 13A-14(A) CERTIFICATION - CFO caxg10ka20060630ex31-2.htm EX-31.2 8657
4 RULE 13A-14(B) CERTIFICATION caxg10ka20060630ex32.htm EX-32 5526
  Complete submission text file 0001096906-09-001137.txt   722795
Mailing Address 40 WALL STREET, 28TH FLOOR NEW YORK NY 10005
Business Address 40 WALL STREET, 28TH FLOOR NEW YORK NY 10005 646-512-5662
CHINA AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-32674 | Film No.: 091084218
SIC: 2834 Pharmaceutical Preparations